Qorvo Insider Notice: 13,612 Shares to Be Sold on NASDAQ

Rhea-AI Filing Summary

Form 144 filing for Qorvo, Inc. (QRVO) notifies the proposed sale of 13,612 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $1,293,140.00. The filing lists the approximate sale date as 09/22/2025 and identifies the securities exchange as NASDAQ. The number of shares outstanding is reported as 92,654,264, providing context for the size of the proposed sale relative to the company's outstanding equity.

The shares being offered were acquired in several restricted stock vesting events from the issuer as compensation on 05/14/2024 (4,309 shares), 11/07/2024 (468 shares), 05/05/2025 (3,689 shares), 05/15/2025 (3,016 shares), and 08/05/2025 (2,130 shares). The filer reports no securities sold during the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Clear disclosure of the proposed sale: 13,612 shares with an aggregate market value of $1,293,140.00.
• Acquisition details provided: each lot is identified as restricted stock vesting and paid as compensation, with specific dates and share counts.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 13,612 shares valued at $1.29M; disclosures indicate compensation-based acquisitions.

The filing is a standard Rule 144 notice indicating an intended sale through a broker on NASDAQ and specifying the aggregate market value and outstanding share count. All listed acquisitions are described as restricted stock vesting and paid as compensation on the dates provided. There are no reported sales in the prior three months, which limits recent disposition activity disclosed in this form. For investors, the document provides transparent, transaction-level detail but contains no operational or financial performance data.

Corporate Governance Expert

TL;DR: Transparent disclosure of planned insider sale and vesting history; no indications of trading-plan reliance or material undisclosed information.

The filer executes the attestation required by the form that they are not aware of undisclosed material adverse information. The acquisition history shows multiple restricted stock vesting events from the issuer, with payment characterized as compensation. The remarks section includes the standard notice language about Rule 10b5-1 plans but does not provide a plan-adoption date, so no explicit trading-plan reliance is stated. The filing is procedural and addresses required compliance elements for an insider disposition.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13612	1293140.00	92654264	09/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/14/2024	Restricted Stock Vesting	Issuer			4309	05/14/2024	Compensation
Common	11/07/2024	Restricted Stock Vesting	Issuer			468	11/07/2024	Compensation
Common	05/05/2025	Restricted Stock Vesting	Issuer			3689	05/05/2025	Compensation
Common	05/15/2025	Restricted Stock Vesting	Issuer			3016	05/15/2025	Compensation
Common	08/05/2025	Restricted Stock Vesting	Issuer			2130	08/05/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the QRVO Form 144 disclose about the proposed sale?

The filing notifies a proposed sale of 13,612 common shares through Fidelity Brokerage Services with aggregate market value of $1,293,140.00, approximate sale date 09/22/2025, on NASDAQ.

How were the shares being sold acquired according to the filing?

All listed shares were acquired via restricted stock vesting from the issuer and characterized as compensation on the dates shown (e.g., 05/14/2024: 4,309 shares).

Does the filer report any securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

What representation does the seller make about undisclosed information?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Is there an indicated reliance on a Rule 10b5-1 trading plan in this filing?

No plan-adoption date or explicit statement of reliance on a Rule 10b5-1 plan is provided in the filing's remarks.